This content is for BOPSS members only:
Click here to login
BOPSS: Please complete our member survey
Access to Intraoperative Tumour Margin Control: A Postcode Lottery?
Authors:
Huw Oliphant1, Tom Oliphant2, Lucy Clarke3, Henry Smith3, Colin Vize4, Saul Rajak1
Author Affiliations:
1) Sussex Eye Hospital, Brighton Sussex University Hospital, Eastern Road, Brighton, BN2 5B
2) Department of Dermatology, Royal Victoria Infirmary, Queen Victoria Road, Newcastle Upon Tyne, NE1 4LP
3) Newcastle Eye Centre, Royal Victoria Infirmary, Queen Victoria Road, Newcastle Upon Tyne, NE1 4LP
4) Eye, Ear and Mouth Unit, Maidstone Hospital, Hermitage Lane, Maidstone, ME16 9QQ
5) Hull & East Yorkshire Eye Hospital, Fountain Street, HU3 2JZ Kingston Upon Hull, United Kingdom
Excision with histological examination is the most widely used treatment modality for periocular tumours in the UK. Intra-operative margin control (IOMC) is increasingly being utilised, though practice is currently highly variable. Access to different forms of IOMC varies significantly across the UK, with some centres having ready access to Mohs Micrographic Surgery (MMS), and some centres never using any form of IOMC.
Intra-operative margin control probably gives a slightly higher chance of complete tumour excision compared with post-operative histological examination, which may impact upon morbidity and recurrence risk, particularly for some tumour types. The predominant methods of IOMC available to UK ophthalmologists are MMS, fast frozen section (FFS) and fast paraffin (FP).
This survey aims to assess the provision and utilisation of IOMC across BOPSS members in the United Kingdom. We anticipate the data may help guide recommendations for the optimal management of periocular skin tumours and help provide greater consistency in regional services.
We expect this survey should take less than five minutes of your time, and greatly appreciate your interest and participation.
